Related Experiment Video
Updated: Aug 15, 2026

In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
Published on: May 8, 2014
Oxygen toxicity
1Division of Pulmonary Diseases/Critical Care Medicine, University of Texas Health Science Center, San Antonio.
Abstract:
Ventilating patients with elevated oxygen tensions alters normal respiratory physiology and may damage lung tissue, depending on coexisting host and iatrogenic factors. Pulmonary oxygen toxicity begins at a cellular level when the generation of reduced oxygen intermediates exceeds local defenses. The mainstay of therapy is prevention. Supplemental oxygen should be prescribed at the lowest concentration possible that will still allow adequate tissue oxygenation. Presently, no specific therapeutic interventions are approved for use in humans to treat pulmonary oxygen toxicity. New agents that act as free radical scavengers or reduce free radical formation may prove useful in future clinical trials based on many of the scientific studies summarized in this review.
Insights
High oxygen levels can harm lung tissue by disrupting normal breathing and causing cellular damage. Prevention through careful oxygen prescription is key, as no direct treatments currently exist for oxygen toxicity.
Area of Science:
- Pulmonary Medicine
- Cellular Biology
- Critical Care
Background:
- Elevated oxygen tensions during mechanical ventilation disrupt respiratory physiology.
- This can lead to lung tissue damage due to cellular-level oxidative stress.
- Host factors and iatrogenic causes influence the severity of oxygen toxicity.
Purpose of the Study:
- To review the mechanisms of pulmonary oxygen toxicity.
- To discuss preventative strategies for managing patients on supplemental oxygen.
- To explore potential future therapeutic interventions.
Main Methods:
- Literature review of scientific studies on pulmonary oxygen toxicity.
- Analysis of cellular mechanisms of oxygen-induced lung injury.
- Summary of current clinical practices and research findings.
Main Results:
- Pulmonary oxygen toxicity originates at the cellular level from an imbalance between free radical generation and antioxidant defenses.
- Prevention is the primary strategy, involving administration of the lowest effective oxygen concentration.
- No specific human therapies are currently approved for treating established pulmonary oxygen toxicity.
Conclusions:
- Careful management of supplemental oxygen is crucial to prevent lung injury.
- Future research focusing on free radical scavengers may offer therapeutic options.
- Understanding cellular mechanisms is vital for developing treatments for oxygen toxicity.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Oxygen Transport in the Blood
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Drug Toxicity: Dose-Dependent Reactions
Oxygen Requirements and Growth Patterns

